KR102317032B1 - 베라프로스트-314d 일수화물 결정 및 그 제조방법 - Google Patents

베라프로스트-314d 일수화물 결정 및 그 제조방법 Download PDF

Info

Publication number
KR102317032B1
KR102317032B1 KR1020190152168A KR20190152168A KR102317032B1 KR 102317032 B1 KR102317032 B1 KR 102317032B1 KR 1020190152168 A KR1020190152168 A KR 1020190152168A KR 20190152168 A KR20190152168 A KR 20190152168A KR 102317032 B1 KR102317032 B1 KR 102317032B1
Authority
KR
South Korea
Prior art keywords
beraprost
monohydrate
crystalline
solvent
monohydrate form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020190152168A
Other languages
English (en)
Korean (ko)
Other versions
KR20200063070A (ko
Inventor
시-위 웨이
지안-방 젱
Original Assignee
치로게이트 인터내셔날 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 치로게이트 인터내셔날 인코포레이티드 filed Critical 치로게이트 인터내셔날 인코포레이티드
Publication of KR20200063070A publication Critical patent/KR20200063070A/ko
Application granted granted Critical
Publication of KR102317032B1 publication Critical patent/KR102317032B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
KR1020190152168A 2018-11-26 2019-11-25 베라프로스트-314d 일수화물 결정 및 그 제조방법 Active KR102317032B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/199,471 2018-11-26
US16/199,471 US10577341B1 (en) 2018-11-26 2018-11-26 Beraprost-314d monohydrate crystals and methods for preparation thereof

Publications (2)

Publication Number Publication Date
KR20200063070A KR20200063070A (ko) 2020-06-04
KR102317032B1 true KR102317032B1 (ko) 2021-10-26

Family

ID=68655416

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190152168A Active KR102317032B1 (ko) 2018-11-26 2019-11-25 베라프로스트-314d 일수화물 결정 및 그 제조방법

Country Status (6)

Country Link
US (1) US10577341B1 (https=)
EP (1) EP3656767A1 (https=)
JP (1) JP6894489B2 (https=)
KR (1) KR102317032B1 (https=)
CN (1) CN111217782A (https=)
TW (1) TWI724651B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11447440B2 (en) * 2020-10-29 2022-09-20 Chirogate International Inc. Treprostinil monohydrate crystals and methods for preparation thereof
CN115611838A (zh) * 2021-07-15 2023-01-17 四川国为制药有限公司 一种前列环素衍生物的晶型

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59134787A (ja) * 1983-01-19 1984-08-02 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体の製造法
JP4503942B2 (ja) * 2003-06-11 2010-07-14 大正製薬株式会社 止痒剤
CN103717585B (zh) * 2011-06-16 2015-11-25 琅歌生物技术股份有限公司 贝前列素的生产方法
JP2016512833A (ja) * 2013-03-15 2016-05-09 ゲームス・ファーマ・インコーポレイテッド ウイルス感染症の治療薬としてのベラプロスト異性体
CN103242274B (zh) * 2013-05-22 2014-11-05 孙威 一种贝前列素钠化合物及其制备方法
KR20170012314A (ko) * 2014-05-20 2017-02-02 렁 바이오테크놀로지 인크. 베라프로스트 및 그의 유도체의 제조 방법
KR101986966B1 (ko) * 2015-08-12 2019-06-07 유나이티드 쎄러퓨틱스 코포레이션 베라프로스트의 제조 방법
HU231080B1 (hu) * 2016-04-05 2020-07-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Eljárás optikailag aktív Beraprost előállítására
KR101777632B1 (ko) * 2016-04-11 2017-09-12 연성정밀화학(주) 베라프로스트 나트륨 결정형 및 이의 제조방법

Also Published As

Publication number Publication date
US10577341B1 (en) 2020-03-03
KR20200063070A (ko) 2020-06-04
TW202021960A (zh) 2020-06-16
EP3656767A1 (en) 2020-05-27
TWI724651B (zh) 2021-04-11
JP2020083892A (ja) 2020-06-04
CN111217782A (zh) 2020-06-02
JP6894489B2 (ja) 2021-06-30

Similar Documents

Publication Publication Date Title
CN101573350B (zh) 甲磺酸伊马替尼的多晶型及其制备方法以及无定形和α型的甲磺酸伊马替尼
EP3344607B1 (en) Solid state forms of selexipag
EP4303212B1 (en) Hydroxytyrosol nicotinamide eutectic crystal, and preparation method therefor and composition thereof
KR102377950B1 (ko) 베라프로스트-314d 및 그 제조방법
KR102317032B1 (ko) 베라프로스트-314d 일수화물 결정 및 그 제조방법
JP2016183193A (ja) フィダキソマイシンの固体状形態およびその調製方法
KR102466729B1 (ko) 헥사데실 트레프로스티닐 결정 및 그 제조방법
WO2008010087A2 (en) Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
KR20250054104A (ko) 테고프라잔 결정형 b 및 이의 제조방법
KR102709537B1 (ko) 초순수 트레프로스티닐의 효율적인 결정화 방법 및 그로부터 제조된 결정
TWI857250B (zh) 單水合曲前列環素晶體及其製備方法
TWI777535B (zh) 用於苯并茚前列腺素之中間物的晶體及其製備方法
AU2017329049A1 (en) Process for the preparation of pure and stable crystalline Raltegravir potassium Form 3
CN101384589A (zh) 卡麦角林和其新型多晶型物的生产方法

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 5